Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Sarcoma
Interventions: DRUG: bortezomib|DRUG: gemcitabine hydrochloride
Sponsor: Masonic Cancer Center, University of Minnesota